Molina Healthcare stock holds near $200 as July earnings beat supports 2026 outlook

Molina Healthcare Inc. (US60855R1005) stock has been trading close to the $200 mark as of August 31, 2026, supported by a recent earnings beat and solid revenue growth that underpin the company’s 2026 outlook.

Stock trades below 52-week high

Per a late August quote snapshot, Molina Healthcare stock was at $200.03 on August 31, 2026, giving the managed-care specialist a market capitalization of $10.44 billion and placing the shares 18.0 percent below their 52-week high of $244.89 and 65.2 percent above their 52-week low of $121.06. The same data set shows a 52-week trading range between $121.06 and $244.89, indicating that the current level sits in the upper half of the past year’s band, but still leaves room before retesting prior highs.

Intraday commentary from another market source on August 31, 2026, cited the stock trading at $197.73, down 1.1 percent on the day and testing support around $196.50, highlighting that short-term volatility has persisted even as the longer-term trend remains positive. A separate institutional filing reported that an investment entity had initiated a position in Molina Healthcare, a sign that professional investors remain engaged with the name at current valuation levels.

July earnings beat and revenue growth

The latest reported quarter, released on July 22, 2026, showed earnings of $1.51 per share on $10.87 billion in revenue, beating the consensus earnings forecast of $1.39 per share and exceeding the $10.83 billion revenue estimate. That equates to an earnings surprise of $0.12 per share, or 8.6 percent above the forecast, and a revenue beat of $0.04 billion versus the estimate.

Recent fundamental snapshots point to strong top-line momentum. Molina Healthcare’s trailing 12-month revenue stands at $35.9 billion, with a net profit margin of 3.0 percent and year-over-year quarterly sales growth of 21.9 percent, confirming that the July report was part of a broader growth trend rather than a one-off result.

Membership is a key driver for managed-care businesses, and Molina has expanded its reach. A sector overview published on September 1, 2026, noted that the company serves roughly 4.9 million members as of June 30, 2026, across 21 states, underscoring the scale of its government-sponsored health plan franchise.

Guidance and 2026 earnings consensus

Management’s current outlook frames premium revenue for 2026 at $42 billion, according to a recent industry report that compares major managed-care players. If achieved, that premium revenue target would be roughly 16.9 percent higher than the trailing 12-month revenue figure of $35.9 billion, highlighting a growth trajectory that extends beyond the latest quarter.

On the earnings side, consensus expectations remain constructive. The same analyst compilation places the 2026 earnings forecast at $5.29 per share, while another quantitative overview of the stock shows that analysts expect adjusted earnings to reach $23.584 per share for the current fiscal year. The discrepancy reflects different methodologies and possible inclusion of longer-term growth assumptions, but both sets of numbers imply continued earnings expansion from the latest quarterly EPS of $1.51.

Short-term revision trends are also supportive. The 2026 earnings consensus has moved 1.1 percent higher over the past 30 days according to the industry report, indicating that analysts have been nudging their forecasts upward in response to the July earnings beat and updated company guidance.

Valuation and peer context

From a valuation perspective, a late August comparison shows Molina Healthcare trading at a price-earnings ratio of 15.6 based on trailing results, with a net profit margin of 3.0 percent and year-over-year quarterly sales growth of 21.9 percent. In the same analysis framework, Molina carries a Value Score of 49, an Estimate Revisions Score of 24 and a Quality Score of 71, signaling an intermediate valuation profile coupled with solid operational quality but more cautious earnings revision metrics.

The same comparison contrasts Molina Healthcare with another managed-care peer, Centene Corp. In that framework, Centene holds a higher Value Score and a stronger Estimate Revisions Score, but Molina’s Quality Score of 71 suggests that its balance sheet, profitability and earnings stability remain attractive on an absolute basis. For investors, the tension between valuation, growth and revision trends across the managed-care group forms part of the broader sector narrative.

Importantly, Molina Healthcare does not currently pay a dividend, according to the peer analysis, which means that the investment case is driven primarily by earnings growth, cash flow generation and potential capital appreciation rather than income.

Sector backdrop and membership scale

The broader managed-care and health insurance sector continues to benefit from growth in government-sponsored plans and ongoing enrollment in Medicaid and related programs. In this context, Molina Healthcare’s focused expertise in government-sponsored healthcare and its presence across 21 states give it a differentiated positioning relative to diversified peers that have larger commercial or Medicare Advantage books.

The membership base of roughly 4.9 million people as of June 30, 2026, highlights the company’s reach within its core markets, with scale that allows for operating efficiencies, network management and care coordination initiatives. Sector commentaries emphasize that such scale can be a competitive advantage when negotiating with providers and managing medical cost trends.

At the same time, the company’s net margin of 3.0 percent on trailing 12-month revenue indicates that profitability remains sensitive to medical loss ratios, regulatory changes and reimbursement dynamics. As a result, guidance on premium revenue and earnings is closely watched by analysts and investors, and the July earnings beat has reinforced confidence that management can navigate these pressures in 2026.

Molina Healthcare’s Medicaid and ACA plans

Molina Healthcare’s core products are Medicaid and Affordable Care Act marketplace plans designed to provide managed-care coverage for low-income individuals and families. The company contracts with state governments to administer Medicaid benefits, receiving per-member-per-month premiums and assuming responsibility for coordinating care, managing networks and controlling costs.

In the ACA marketplace segment, Molina offers individual and family plans in selected states, often focusing on value-oriented offerings that appeal to consumers seeking lower premiums with access to essential health benefits. These plans can be subsidized through federal tax credits, and Molina’s experience in government-sponsored programs gives it an operational edge in administering such products.

The company also participates in other government programs such as Medicare, particularly through Dual Eligible Special Needs Plans that serve individuals eligible for both Medicare and Medicaid. While this segment is smaller than the core Medicaid book, it contributes to diversification and leverages Molina’s expertise in managing complex populations.

Shares hold near $200 level

As of August 31, 2026, Molina Healthcare stock at $200.03 USD trades in the upper half of its 52-week range but remains below the prior high of $244.89, leaving potential upside if the company continues to deliver on its $42 billion premium revenue guidance and if earnings follow the upward revision path seen in recent analyst estimates. The market capitalization of $10.44 billion at that price reflects the scale of the business and the market’s assessment of its growth and risk profile.

Fact box

Company: Molina Healthcare Inc.

ISIN: US60855R1005

Ticker: MOH

Exchange: NYSE

Price (as of August 31, 2026, 4:00 p.m. ET): $200.03 USD

Market cap: $10.44 billion (as of August 31, 2026)

Sector / Industry: Health care - Managed care

Index membership: S&P 500